Ana Martı́nez
Impact in
- Pharmacology top 0.1%
- Cholinesterase and Neurodegenerative Diseases
- Biological Psychiatry top 1%
Papers in
-
- Phosphodiesterase function and regulation 42
- Wnt/β-catenin signaling in development and cancer 31
-
- Synthesis and Biological Evaluation 27
- Synthesis and Characterization of Heterocyclic Compounds 26
- Co-authors
- Ana Castro (57 shared papers)Carmen Gil (120 shared papers)Daniel I. Pérez (47 shared papers)Concepción Pérez (42 shared papers)Mercedes Alonso (7 shared papers)Isabel Dorronsoro (22 shared papers)Hagit Eldar-Finkelman (3 shared papers)Ana Pérez‐Castillo (23 shared papers)
- Journals
- Journal of Medicinal Chemistry (32 papers)European Journal of Medicinal Chemistry (16 papers)Bioorganic & Medicinal Chemistry (16 papers)Tetrahedron (15 papers)PLoS ONE (11 papers)
- Partner nations
- SpainUnited StatesGermany
In The Last Decade
Ana Martı́nez
441 papers receiving 12.3k citations
Peers
Comparison fields: 5 of 153
- Pharmacology 2.9k
- Biological Psychiatry 361
- Computational Theory and Mathematics 1.6k
- Organic Chemistry 2.9k
- Neurology 599
Countries citing papers authored by Ana Martı́nez
This map shows the geographic impact of Ana Martı́nez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Martı́nez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Martı́nez more than expected).
Fields of papers citing papers by Ana Martı́nez
This network shows the impact of papers produced by Ana Martı́nez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Martı́nez. The network helps show where Ana Martı́nez may publish in the future.
Co-authors
The 25 scholars most cited alongside Ana Martı́nez, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 461 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 409 | |
| 2 | 2020 | 335 | |
| 3 | 2011 | 297 | |
| 4 | 2002 | 288 | |
| 5 | 2018 | 223 | |
| 6 | 2005 | 195 | |
| 7 | 2006 | 182 | |
| 8 | 2005 | 169 | |
| 9 | 2000 | 150 | |
| 10 | 2016 | 147 | |
| 11 | 2021 | 146 | |
| 12 | 2005 | 145 | |
| 13 | 2001 | 140 | |
| 14 | 2012 | 138 | |
| 15 | 2009 | 136 | |
| 16 | 2010 | 126 | |
| 17 | 2007 | 119 | |
| 18 | 2008 | 119 | |
| 19 | 2008 | 112 | |
| 20 | 2005 | 108 |
About Ana Martı́nez
Ana Martı́nez is a scholar working on Molecular Biology, Organic Chemistry, Pharmacology, Epidemiology and Infectious Diseases, having authored 461 papers that have together received 12.5k indexed citations. Recurring topics across this work include Cholinesterase and Neurodegenerative Diseases (71 papers), Phosphodiesterase function and regulation (42 papers), Computational Drug Discovery Methods (40 papers), Alzheimer's disease research and treatments (34 papers), Amyotrophic Lateral Sclerosis Research (31 papers), Wnt/β-catenin signaling in development and cancer (31 papers), Synthesis and Biological Evaluation (27 papers) and Synthesis and Characterization of Heterocyclic Compounds (26 papers). The work is most often cited by research in Pharmacology (2.9k citations), Biological Psychiatry (361 citations), Computational Theory and Mathematics (1.6k citations), Organic Chemistry (2.9k citations) and Neurology (599 citations). Ana Martı́nez has collaborated with scholars based in Spain, United States and Germany. Frequent co-authors include Ana Castro, Carmen Gil, Daniel I. Pérez, Concepción Pérez, Mercedes Alonso, Isabel Dorronsoro, Hagit Eldar-Finkelman, Ana Pérez‐Castillo, Nuria E. Campillo and Francisco J. Moreno. Their work appears in journals such as Journal of Medicinal Chemistry, European Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry, Tetrahedron and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.